NewCo专题研讨｜ACCESS ASIA 雅法药通亚洲 BD 论坛 @ JPM 2026

雅法全球生命科学

2025-11-24

13

导读：新生代模式催生全球生物科技新机遇。

新生代模式催生全球生物科技新机遇。
Where fresh models create new global biotech opportunities.

生物科技公司的构建模式正在经历快速变革。
The way biotech companies are built is changing — fast.

如今，最具突破性的创新不再源自传统架构，而是诞生于由精干战略、跨境协同开发与风险投资驱动的大胆新模式。
Today's most successful innovations are no longer coming from traditional structures, but from bold new models driven by lean strategy, cross-border co-development, and venture-backed execution.

在ACCESS ASIA 药通亚洲BD论坛 @ JPM 2026期间，我们特设"Newco模式专题讨论"，将这一变革推向舞台中央——届时将汇聚引领下一轮生物科技增长浪潮的行业领袖，共话未来格局。
At the ACCESS ASIA BD Forum @ JPM 2026, we're bringing this transformation to center stage through a dedicated NewCo panel, featuring some of the most influential voices shaping the next wave of biotech growth.

Newco专题研讨嘉宾
Featured NewCo Panelists

主题：创新未来：NewCo模式如何重塑生物科技的增长与全球化
Topic: Creating the Future: How the NewCo Model Is Redefining Biotech Growth and Globalization

最新议程及新增嘉宾一览，请点击：
Click here to see our most updated agenda/newly added speakers: 
https://biotochina.org/agenda/

美国东海岸NewCo创新中心启动公告
East Coast NewCo Innovation Hub Launch (Announcement)

本届论坛将同步举行"美国东海岸NewCo创新中心"启动仪式。该中心专为助力亚洲生物科技企业加速在美国的研发进程、对接战略合作伙伴而设立。
In this Forum, we will also unveil the US East Coast NewCo Innovation Hub, designed to help Asian biotech innovators accelerate U.S. development and access strategic partners.

亮点前瞻
Key highlight:

美国宾夕法尼亚州政府高级代表已确认出席并致开幕辞
A senior Pennsylvania government representative has been invited to deliver opening remarks during the launch ceremony

更多合作细节与首批入驻创新企业名单将陆续公布。
More details and featured innovators will be released shortly.

最新动态请关注雅法资本领英：
Follow us on LinkedIn to stay updated: 
https://www.linkedin.com/company/yafo-capital/posts/?feedView=all

席位有限 即刻预定
Limited registration slots available

2026年1月11日 | 旧金山洲际酒店（JPM周同期）
January 11, 2026 | InterContinental San Francisco (during JPM Week)

扫码完成注册
Scan the QR code to register

如需推广企业品牌或建立战略合作，请联系：
Interested in promoting your company or partnering with us?

相文迪Wendi Xiang 

wxiang@yafocapital.com

关于ACCESS ASIA 药通亚洲 BD 论坛
About ACCESS ASIA BD Forum

承袭ACCESS CHINA基因的顶级资源对接平台，已实现：
A premier platform continuing the legacy of ACCESS CHINA, connecting:

连接全球药企、投资者与亚洲生物科技创新力量。累计26,500+场次会议，4,800+次合作对接 ，900+项资产展示 。
Global pharma, investors, Asian biotech innovators. 26,500+ session views, 4,800+ partnering requests, 900+ assets showcased.

【声明】内容源于网络

0

0